While no statistically significant difference was observed in the cumulative recurrence rates between the GCs group and the GCs + EBD group at the 1 st, 3rd, 6th, and 12th months after treatment ( P = 0.36, 0.96, 0.78, and 0.28, respectively), the GCs + EBD group showed a trend toward lower recurrence rates at all these time points.
← all excerpts
Does adjunctive endoscopic biliary drainage improve outcomes beyond glucocorticoids alone in IgG4-related pancreatobiliary disease?
1
—
—